Pérez-Díaz M, Alvarado-Gomez E, Magaña-Aquino M, Sánchez-Sánchez R, Velasquillo C, Gonzalez C, Ganem-Rondero A, Martínez-Castañon G, Zavala-Alonso N, Martinez-Gutierrez F
Facultad de Ciencias Quimicas, Universidad Autonoma de San Luis Potosi, Mexico.
Servicio de Epidemiologia del Hospital Central "Dr. Ignacio Morones Prieto", San Luis Potosi, Mexico.
Mater Sci Eng C Mater Biol Appl. 2016 Mar;60:317-323. doi: 10.1016/j.msec.2015.11.036. Epub 2015 Nov 14.
The development of multi-species biofilms in chronic wounds is a serious health problem that primarily generates strong resistance mechanisms to antimicrobial therapy. The use of silver nanoparticles (AgNPs) as a broad-spectrum antimicrobial agent has been studied previously. However, their cytotoxic effects limit its use within the medical area. The purpose of this study was to evaluate the anti-biofilm capacity of chitosan gel formulations loaded with AgNPs, using silver sulfadiazine (SSD) as a standard treatment, on strains of clinical isolates, as well as their cytotoxic effect on human primary fibroblasts. Multi-species biofilm of Staphylococcus aureus oxacillin resistant (MRSA) and Pseudomonas aeruginosa obtained from a patient with chronic wound infection were carried out using a standard Drip Flow Reactor (DFR) under conditions that mimic the flow of nutrients in the human skin. Anti-biofilm activity of chitosan gels and SSD showed a log-reduction of 6.0 for MRSA when chitosan gel with AgNPs at a concentration of 100 ppm was used, however it was necessary to increase the concentration of the chitosan gel with AgNPs to 1000 ppm to get a log-reduction of 3.3, while the SSD showed a total reduction of both bacteria in comparison with the negative control. The biocompatibility evaluation on primary fibroblasts showed better results when the chitosan gels with AgNPs were tested even in the high concentration, in contrast with SSD, which killed all the primary fibroblasts. In conclusion, chitosan gel formulations loaded with AgNPs effectively prevent the formation of biofilm and kill bacteria in established biofilm, which suggest that chitosan gels with AgNPs could be used for prevention and treatment of infections in chronic wounds. The statistic significance of the biocompatibility of chitosan gel formulations loaded with AgNPs represents an advance; however further research and development are necessary to translate this technology into therapeutic and preventive strategies.
慢性伤口中多物种生物膜的形成是一个严重的健康问题,主要会产生对抗菌治疗的强大抵抗机制。此前已对将银纳米颗粒(AgNPs)用作广谱抗菌剂进行了研究。然而,它们的细胞毒性作用限制了其在医学领域的应用。本研究的目的是评估负载AgNPs的壳聚糖凝胶制剂的抗生物膜能力,以磺胺嘧啶银(SSD)作为标准治疗方法,用于临床分离菌株,并评估其对人原代成纤维细胞的细胞毒性作用。从一名慢性伤口感染患者身上分离出的耐甲氧西林金黄色葡萄球菌(MRSA)和铜绿假单胞菌的多物种生物膜,是在模拟人体皮肤营养物质流动的条件下,使用标准滴流反应器(DFR)形成的。壳聚糖凝胶和SSD的抗生物膜活性显示,当使用浓度为100 ppm的负载AgNPs的壳聚糖凝胶时,MRSA的对数减少量为6.0,然而,有必要将负载AgNPs的壳聚糖凝胶浓度提高到1000 ppm才能使对数减少量达到3.3,而SSD与阴性对照相比显示两种细菌均完全减少。对原代成纤维细胞的生物相容性评估显示,即使在高浓度下测试,负载AgNPs的壳聚糖凝胶的结果也更好,与之形成对比的是,SSD杀死了所有原代成纤维细胞。总之,负载AgNPs的壳聚糖凝胶制剂能有效防止生物膜形成并杀死已形成生物膜中的细菌,这表明负载AgNPs的壳聚糖凝胶可用于预防和治疗慢性伤口感染。负载AgNPs的壳聚糖凝胶制剂生物相容性的统计学意义代表了一项进展;然而,要将这项技术转化为治疗和预防策略,还需要进一步的研究和开发。